Thursday, July 09, 2015 8:54:28 PM
Let's look at what's on tap for the next few weeks:
- next week is the official closing of the ESS acquisition
- the following week AMBS silver sponsor(cost $50k) to announce positive LymPro data at the AAIC
- the last week of July with the share price maintaining above $4 AMBS will qualify for NASDAQ uplist
- that will likely make IPO/uplist in early to mid August raising between $20 million - $150 million with the shelf offering
- mixed in that time frame we get first patient dosing for Eltoprazine Phase 2 trail and ESS Phase 2 trail initiating
Look at my post history, I am not one for predictions but I am gonna say the bottom is in!!
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM